Corbus Pharmaceuticals Holding (CRBP) Stock Analysis

Corbus Pharmaceuticals Holding (CRBP) is a publicly traded company in the HEALTHCARE sector. It trades at $7.54, carries a market capitalization of $143.59M. This page summarizes the public market data, fundamentals, and frequently asked questions for CRBP, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $7.54
• Market Cap: $143.59M
• EPS: $-5.74
• 52-Week High: $20.56
• 52-Week Low: $6.72

Market Sentiment

Corbus Pharmaceuticals Holding currently has a Neutral sentiment score of -0.08.

About Corbus Pharmaceuticals Holding

Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage biotechnology company located in Norwood, Massachusetts, specializing in the development of innovative therapies that target the endocannabinoid system to tackle pressing unmet medical needs in autoimmunity, fibrosis, and oncology. The company boasts a diverse and promising pipeline aimed at enhancing treatment modalities for chronic diseases, with the potential to reshape patient care paradigms. With its distinct approach to cannabino...

GNG Research Analysis

GNG Research scores Corbus Pharmaceuticals Holding (CRBP) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CRBP.

Frequently Asked Questions

Does CRBP pay dividends?

Corbus Pharmaceuticals Holding (CRBP) does not currently pay a regular dividend.

What is CRBP's market cap?

Corbus Pharmaceuticals Holding (CRBP) has a market capitalization of $143.59M with a current stock price of $7.54.